As both RUNX3 and TGF-β play a tumor suppressor role in cancer development, their elevated CpG methylations inhibited their expression in metastatic cancer model thereby contributing to higher degree of malignancy. This evidence concerns the gene RUNX3 and metastatic malignant neoplasm.